Endoluminal brachytherapy: Bronchus and oesophagus

Area of Science:

• Oncology
• Radiation Oncology
• Medical Physics

Background:

• Endobronchial tumors and esophageal tumors present significant treatment challenges.
• Brachytherapy, a form of radiation therapy, is being explored for both curative and palliative applications in these conditions.
• Current treatment paradigms include external beam radiation therapy, laser therapy, and metallic stents, each with limitations.

Purpose of the Study:

• To evaluate the efficacy of endobronchial brachytherapy as a curative and palliative treatment for endoluminal tumors.
• To assess the role of oesophageal brachytherapy as a palliative treatment and in combination with external beam radiotherapy for esophageal diseases.
• To compare brachytherapy outcomes with existing treatment modalities.

Main Methods:

• Review of clinical data and outcomes for patients treated with endobronchial brachytherapy.
• Analysis of oesophageal brachytherapy for palliative care and in combination with external beam radiotherapy.
• Comparison of side effect profiles and quality of life data between brachytherapy and other interventions.

Main Results:

• Endobronchial brachytherapy can achieve high local control rates for limited endobronchial tumors when used curatively.
• Palliative endobronchial brachytherapy improves thoracic symptoms in over 80% of cases but is less effective than external beam radiation therapy for palliation.
• Oesophageal brachytherapy is a valuable palliative option with fewer side effects and better quality of life than metallic stents.
• Current evidence does not support combined external beam radiotherapy and oesophageal brachytherapy for locally advanced esophageal tumors, but it shows promise for superficial diseases.

Conclusions:

• Endobronchial brachytherapy is a viable treatment option for endoluminal tumors, offering both curative and palliative benefits.
• Oesophageal brachytherapy presents a favorable palliative alternative to metallic stents, particularly regarding side effects and quality of life.
• Further research is warranted to define the optimal role of combined radiotherapy techniques for esophageal cancers, especially for superficial disease presentations.